[Estrogen-resistant prostatic cancer with bone metastases: palliative chemotherapy with 5-fluorouracil and cyclophosphamide].
D001859:Bone Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D010166:Palliative Care; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D004967:Estrogens; D003520:Cyclophosphamide; D005472:Fluorouracil
Cancer de la prostate résistant aux estrogènes avec métastases osseuses: chimiothérapie palliative par le 5 fluoro-uracile et le cyclophosphamide.